(ALHC) Alignment Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US01625V1044
ALHC EPS (Earnings per Share)
ALHC Revenue
ALHC: Senior Healthcare, Medicare Plans, Customized Healthcare
Alignment Healthcare LLC is a healthcare platform that provides personalized care to seniors in the US through its Medicare Advantage plans, operating with a consumer-centric approach. The company, founded in 2013 and based in Orange, California, has established itself as a significant player in the healthcare services sector.
From a technical analysis perspective, the stocks current price is $15.22, slightly above its 20-day Simple Moving Average (SMA) of $15.11, indicating a potential bullish trend. However, it is below its 50-day SMA of $16.75, suggesting a short-term bearish sentiment. The stocks Average True Range (ATR) is $0.78, representing a 5.12% daily price movement, indicating moderate volatility.
Fundamentally, Alignment Healthcare has a market capitalization of $3.04 billion, with a negative Return on Equity (RoE) of -81.24%, indicating that the company is currently not generating profits for its shareholders. The absence of a Price-to-Earnings (P/E) ratio, both current and forward, further reinforces this notion, as the company is likely operating at a loss.
Analyzing the support and resistance levels, the stock has resistance at $15.6 and $17.6, with support levels at $14.6, $11.7, $10.9, and $10.0. Given the current price and technical indicators, a potential forecast is that the stock may face resistance at $15.6 in the short term. If it breaks through this level, it could continue its upward trend towards $17.6. Conversely, if it fails to break through $15.6, it may retreat to its support level at $14.6. A breach of this support could lead to further decline towards $11.7.
Combining both technical and fundamental analysis, a possible forecast is that the stock may experience a short-term correction due to its current bearish sentiment and negative RoE. However, if the company can demonstrate a clear path to profitability and improve its financials, the stock may regain investor confidence, potentially driving the price upwards. Monitoring the companys progress and adjusting the forecast accordingly will be crucial in determining the stocks future trajectory.
Additional Sources for ALHC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ALHC Stock Overview
Market Cap in USD | 2,956m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2021-03-26 |
ALHC Stock Ratings
Growth Rating | 1.39 |
Fundamental | -6.25 |
Dividend Rating | 0.0 |
Rel. Strength | 98.2 |
Analysts | 4.09 of 5 |
Fair Price Momentum | 14.79 USD |
Fair Price DCF | 1.55 USD |
ALHC Dividends
Currently no dividends paidALHC Growth Ratios
Growth Correlation 3m | -79.2% |
Growth Correlation 12m | 89.8% |
Growth Correlation 5y | -35.6% |
CAGR 5y | -3.99% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | 0.40 |
Alpha | 74.84 |
Beta | 0.841 |
Volatility | 61.64% |
Current Volume | 2485.5k |
Average Volume 20d | 2732.4k |
As of June 18, 2025, the stock is trading at USD 14.57 with a total of 2,485,478 shares traded.
Over the past week, the price has changed by -0.55%, over one month by -10.28%, over three months by -9.45% and over the past year by +84.43%.
Neither. Based on ValueRay´s Fundamental Analyses, Alignment Healthcare is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -6.25 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALHC is around 14.79 USD . This means that ALHC is currently overvalued and has a potential downside of 1.51%.
Alignment Healthcare has received a consensus analysts rating of 4.09. Therefor, it is recommend to buy ALHC.
- Strong Buy: 6
- Buy: 1
- Hold: 3
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, ALHC Alignment Healthcare will be worth about 16.6 in June 2026. The stock is currently trading at 14.57. This means that the stock has a potential upside of +14.21%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 18.2 | 25.1% |
Analysts Target Price | 18.2 | 25.1% |
ValueRay Target Price | 16.6 | 14.2% |